| Product Information | 
	
| Product name | Enoxaparin Sodium | 
| CAS No. | 679809-58-6 | 
| Molecular Formula | (C12H16NS2Na3)n | 
| Molecular Weight | 288.428 | 
| Molecular Structure |  | 
| Quality Standard | 99% up by HPLC | 
| Appearance | White or almost white powder | 
	
| COA | 
	
| ANALYSIS | SPECIFICATION | RESULTS | 
| Appearance | White or almost white powder, | White powder | 
| Solubility | Hygroscopic. Solubility: Freely soluble in water | Complies | 
| Identification | A: 13C-NMR: the spectrum should be similar with that of standard. Ethanol peak may exist at 18.7ppm±0.5ppm, benzaledyde peak may exist at 131.6ppm±0.5ppm and130.9ppm±0.5ppm in spectrum obtained from test sample. | The spectrum of test solution is similar to that of enoxaparin sodium RS, Ethanol peak exist at 18.7ppm±0.5ppm. No benzaldehyde peak exist at 131.6ppm±0.5ppm and 130.9ppm±0.5ppm. | 
| B: 1,6 anhydro derivative: 15% to 25% | 20.3% | |
| C: The mass-average relative molecular mass ranges between 3800 and 5000 Da. The mass percentage of chains lower than 2000 Da. ranges bwtween 12.0% and 20% The mass percentage of chains between 2000 and 8000 ranges between 68.0% and 82.0% | The mass-average relative molecular mass : 4384 The mass percentage of chains lower than 2000 Da.: 18.9% The mass percentage of chains between 2000 and 8000 Da.: 70.7% | |
| D: Anti-factor Xa/Anti-factor IIa: 3.5 to 5.3 | 3.4 | |
| E: Sodium: It complies with the test of sodium | Complies | |
| Appearance of solution | The solution is clear and not more intensely colored than reference solution | Complies | 
| Specific absorbance | The specific absorbance determined at 231 nm ranges between 14.0 and 20.0(dried substance) | 17.3 | 
| Bacterial endotoxins | < 0.01 IU/Anti-FXa U activity | < 0.01 IU/Anti-FXa U activity | 
| pH | 6.2 to 7.7 | 7.1 | 
| Loss on drying | ≤10.0% | 1.4% | 
| Nitrogen | 1.5% to 2.5% (on dried substance) | 2.0% | 
| Sodium content | 11.3%-13.5%(on dried substance) | 12.4% | 
| SO42-/COO- | ≥1.8 | 2.4 | 
| Benzyl alcohol | ≤0.1%(m/m) | 0.02% | 
| Residual solvents | DMF ≤880ppm | Below detection limit | 
| Ethanol≤5000ppm | 891ppm | |
| Anti-factor Xa activity | 90IU to 125 IU/mg(on dried substance) | 981 IU/mg | 
| Anti-factor IIa activity | 20.0IU to 35.0IU(on dried substance) | 28.8IU/mg | 
| Micro organisms | A: TAMC: ≤ 100CFU/g TYMC: ≤ 10CFU/g | 
 < 10CFU/g <10CFU/g | 
| B: Specified micro organisms Escherichia coli Salmonella | 
 Negative Negative Negative | |
| Free sulfate content | ≤0.50% | 0.11% | 
| Conclusion | The sample complies with the requirements of EP10.5. | |
	
| Usage | 
	
What is Enoxaparin sodium?
	
  Enoxaparin sodium is a new anticoagulant. It is used for various indications
including prevention of deep vein thrombosis (DVT). Enoxaparin sodium is a hemodilution drug prepared from heparin sodium, and its active
ingredient is a mixture of natural polysaccharides. 
	
 Enoxaparin sodium is intended for use in the
treatment of deep vein thrombosis; prophylaxis of ischemic complications of unstable
angina and non-Q-wave myocardial infarction, and treatment of acute deep vein
thrombosis. Besides, Enoxaparin Sodium also can be used as a biomarker
for diagnosis of atrial fibrillation cause of stroke. 
	
	*Products under the patent are only for R&D use